News and Research

New Radiation Oncologist boosts skin and lung radiation capabilities

Dr Arunachalam has recently joined ARO as a Radiation Oncologist Consultant. His specialties include lung, skin, sarcoma, as well as Stereotactic Ablative Radiotherapy, Non-malignant and Palliative cases. He is an enthusiastic, passionate and caring Radiation Oncologist who works at Auckland City Hospital. 



Dual Screening for Head and Neck and Lung Cancer

Adding head and neck cancer screenings to recommended lung cancer screenings would likely improve early detection and survival, according to a multidisciplinary team led by scientists affiliated with the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC CancerCenter.


Stereotactic body radiation therapy plus chemotherapy improves survival

A clinical trial that combined stereotactic body radiation therapy (SBRT) with a specific chemotherapy regimen more than doubled survival rates for certain patients with stage 4 lung cancer, according to a new report in the Journal of Clinical Oncology 


Lung Cancer and Radiation Therapy - Updates in Cancer Care Symposium Presentation

Dr Lao presented at the Updates in Cancer Care Symposium on 15th November, held on the Mercy Hospital site.
This presentation covered the use of Stereotactic Ablative Radiation Therapy in the treatment of Lung Cancer.



Even With a Little Weight Gain, Quitting Smoking Is Still A Healthier Choice

A new study finds that even if you do add a few kilos once you quit smoking, your post-cigarette health is still much better than if you'd kept on smoking.


Stereotactic radiation therapy in early stage NSCLC

Stereotactic body radiation therapy can be an effective treatment for early stage non-small cell lung cancer


Two Regimens for Patients with Non-small Cell Lung Cancer

There are patients with stage I–III non-small cell lung cancer (NSCLC) who are not suitable for curative radical chemoradiation therapy. There are patients with an isolated solitary extracranial metastasis who have improved outcomes compared with those with cranial or multiple metastases. Patients of good performance status receiving moderate dose radiation therapy have improved survival. Two regimens of moderate dose chemoradiation therapy for such patients were compared in a randomized phase II trial.



New radiation therapy shows promise in lung cancer

Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer


Multidisciplinary Lung Metastases Clinic

Research into the value of multidisciplinary discussions with regard to patient care